The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNG.L Regulatory News (HNG)

  • There is currently no data for HNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Unsecured Convertible Loan Notes

19 Dec 2022 12:20

RNS Number : 1921K
Hawkwing PLC
19 December 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"), AND IS DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF MAR.

 

19 December 2022

 

Hawkwing plc

("Hawkwing" or the "Company")

Update on Hawkwing's Unsecured Convertible Loan Notes ("CULS")

 

Further to the announcement on 12 December 2022, a hearing took place in the Insolvency and Companies List of the High Court on 16 December 2022 in respect of the court application from Cadwalader, Wickersham & Taft LLP acting for Hanover Investors Management LLP on behalf of Hanover Catalyst Fund ("Hanover") seeking to appoint Sarah Megan Rayment and Robert John Armstrong of Kroll Advisory Limited as administrators to the Company. Hanover's application for an immediate administration order was rejected, and a full hearing of the application will take place in February.

 

As a result of the above the Company's application to the court to obtain injunctive relief in respect of the statutory demand made by Hanover was adjourned until February, when both matters will be heard together. Hanover alleges a breach has occurred which is an event of default, and is the basis of the statutory demand. This breach has been waived by a majority of CULS holders and, in accordance with the terms and conditions of the CULS, this waiver binds all CULS holders.

 

The Company will give a further update to the market in due course.

 

Important Notices

This announcement contains 'forward‐looking statements' concerning the Company that are subject to risks and uncertainties. Generally, the words 'will', 'may', 'should', 'continue', 'believes', 'targets', 'plans', 'expects', 'aims', 'intends', 'anticipates' or similar expressions or negatives thereof identify forward‐looking statements. These forward‐looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward‐looking statements. Many of these risks and uncertainties relate to factors that are beyond the Company's ability to control or estimate precisely. The Company cannot give any assurance that such forward‐looking statements will prove to have been correct. The reader is cautioned not to place undue reliance on these forward‐looking statements, which speak only as of the date of this announcement. The Company does not undertake any obligation to update or revise publicly any of the forward‐looking statements set out herein, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

Nothing contained herein shall be deemed to be a forecast, projection or estimate of the future financial performance of the Company.

 

Enquiries:

 

Hawkwing plc

Keith Sadler, Senior Independent Non-Executive Director

Dwight Mighty, Non-Executive Director

 

+44 (0)20 4582 3500

 

Gracechurch Group

Harry Chathli, Alexis Gore

+44 (0)20 4582 3500

 

About Hawkwing plc

For more information, please refer to the Company's website: www.hawkwing.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURLKLFFLLLFFBQ
Date   Source Headline
9th Jan 20249:54 amRNSIntention to Delist
4th Jul 20234:31 pmRNSAppointment of voluntary liquidators
19th May 20236:07 pmRNSJoint Administrators' Application to Court
6th Apr 20237:00 amRNSJoint Administrators’ Statement of Proposals
13th Feb 20232:41 pmRNSAppointment of Joint Administrators
19th Dec 202212:20 pmRNSUpdate on Unsecured Convertible Loan Notes
12th Dec 20227:00 amRNSUpdate on Unsecured Convertible Loan Notes
2nd Dec 202210:13 amRNSUpdate on Unsecured Convertible Loan Notes
30th Nov 20224:41 pmRNSFurther update on Hawkwing loan to IFG (SPP)
28th Nov 20227:00 amRNSUpdate on Hawkwing’s CULS
27th Oct 20225:31 pmRNSFurther update on Hawkwing loan to IFG
26th Oct 20225:26 pmRNSUpdate on Hawkwing loan to IFG
12th Oct 20228:00 amRNSDirector Declaration
30th Sep 20225:50 pmRNSInterim Results
24th Jun 202212:25 pmRNSResult of Annual General Meeting
1st Jun 20224:45 pmRNSAnnual Report & Accounts 2021 and Notice of AGM
1st Jun 20227:00 amRNSFinal Results
11th Feb 20227:45 amRNSChange of Auditor
24th Dec 20217:00 amRNSRelisting
13th Dec 20217:00 amRNSIFG withdrawal from heads of terms
23rd Sep 20217:00 amRNSInterim Results
17th Sep 20217:00 amRNSHawkwing loans IFG £13.7 million for acquisitions
16th Sep 20217:00 amRNSUpdate on Hawkwing loan to IFG
12th Aug 20217:00 amRNSHawkwing raises £16.5 million
12th Jul 20217:50 amRNSPotential Acquisition and Suspension of Listing
29th Apr 202111:48 amRNSResult of AGM
7th Apr 20211:29 pmRNSAnnual Report & Accounts 2020 and Notice of AGM
6th Apr 20212:15 pmRNSFinal Results
9th Mar 20211:52 pmRNSHolding(s) in Company
18th Jan 202111:05 amRNSSecond Price Monitoring Extn
18th Jan 202111:00 amRNSPrice Monitoring Extension
18th Jan 20219:05 amRNSSecond Price Monitoring Extn
18th Jan 20219:00 amRNSPrice Monitoring Extension
14th Oct 20207:00 amRNSInterim Results
5th Oct 20205:27 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSHolding(s) in Company
30th Sep 20204:53 pmRNSHolding(s) in Company
30th Sep 202010:48 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSAdmission to Standard List
29th Sep 20205:30 pmRNSHawkwing
23rd Sep 20201:28 pmRNSPublication of Prospectus
26th Aug 20207:00 amRNSUpdate on Move to Standard List of the Main Market
12th Aug 20207:00 amRNSUpdate on Move to Standard List of the Main Market
1st Jul 202011:01 amRNSPlacing to raise approximately £1.3m
29th Jun 20202:31 pmRNSResult of AGM and General Meeting
12th Jun 20205:09 pmRNSProposed admission to the Main Market
4th Jun 20202:56 pmRNSAnnual Report & Accounts 2019 and Notice of AGM
4th Jun 20207:00 amRNSFinal Results
6th Mar 20207:30 amRNSSuspension - Hawkwing Plc
6th Mar 20207:00 amRNSSuspension of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.